首页 › 基金 › Contrarius Group Holdings Ltd › BEAM
Contrarius Group Holdings Ltd 对 BEAM 的持仓历史
BEAM THERAPEUTICS INC · 医疗保健
Contrarius Group Holdings Ltd 在 Q3 2026 的 13F 申报中披露持有 BEAM(BEAM THERAPEUTICS INC)522,461 股,市值约 US$12.8M,约占其申报组合的 0.62%,在其申报持仓中市值排名第 22 位。 Contrarius Group Holdings Ltd 最近 7 个申报季度中有 5 个季度披露了 BEAM 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-10 · 来源: SEC EDGAR Form 13F-HR
Contrarius Group Holdings Ltd 对 BEAM 的持仓演变
Contrarius Group Holdings Ltd 于 Q1 2025 首次披露 BEAM 持仓:126,470 股(约 US$2.5M)。 该持仓在 Q2 2026 达到峰值 1,614,538 股,市值约 US$55.4M。 在 5 次申报中,Contrarius Group Holdings Ltd 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 522,461 股、市值约 US$12.8M,环比减持 -1,092,077 股。。 持仓曾出现大幅变动:Q2 2026 增持约 203% (随后一个季度股价下跌 32%)、Q3 2026 减持约 68% (随后一个季度股价上涨 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 126.47K | $2.47M | 新进 |
| Q3 2025 | 1.53M | $37.21M | 新进 |
| Q1 2026 | 533.44K | $12.71M | 新进 |
| Q2 2026 | 1.61M | $55.41M | 增持 |
| Q3 2026 | 522.46K | $12.77M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 BEAM 与 13F 数据
BEAM(BEAM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 BEAM,申报仓位最大的包括:法拉龙资本管理 (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), 方舟投资 (US$351.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BEAM 的基金
- 法拉龙资本管理 10.24M 股 · $351.31M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 10.24M 股 · $351.31M · Q2 2026
- 方舟投资 10.23M 股 · $351.26M · Q2 2026
- ARCH Venture Management, LLC 4.54M 股 · $155.77M · Q2 2026
- Amova Asset Management Americas, Inc. 3.46M 股 · $118.54M · Q2 2026
- Kynam Capital Management, LP 2.84M 股 · $97.50M · Q2 2026
- Casdin 资本 1.35M 股 · $46.33M · Q2 2026
- Redmile Group, LLC 1.16M 股 · $39.96M · Q2 2026
- Deep Track Capital, LP 1.00M 股 · $34.32M · Q2 2026
更多关于 Contrarius Group Holdings Ltd
常见问题
How long has Contrarius Group Holdings Ltd held BEAM?
Contrarius Group Holdings Ltd has disclosed BEAM holdings in 5 of the last 7 reported quarters, going back to Q1 2025.
What is Contrarius Group Holdings Ltd's current position in BEAM?
As of Q3 2026, Contrarius Group Holdings Ltd holds 522.46K shares of BEAM (BEAM THERAPEUTICS INC), valued at $12.77M, representing 0.62% of its reported portfolio and ranking #22.
Has Contrarius Group Holdings Ltd been buying or selling BEAM?
In the latest 13F filing (Q3 2026), Contrarius Group Holdings Ltd reduced its position in BEAM. The position peaked in Q2 2026 at 1.61M shares.
Which other funds hold BEAM?
Other major institutional holders of BEAM include 法拉龙资本管理, FARALLON CAPITAL MANAGEMENT, L.L.C., 方舟投资, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.